A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

Buch, Stephan, Stickel, Felix, Trépo, Eric, Way, Michael, Herrmann, Alexander, Nischalke, Hans Dieter, Brosch, Mario, Rosendahl, Jonas +40 more·2015·Nature Genetics
DOI 10.1038/ng.3417

Cited by (563)

Items 401–500 of 563

  1. Current and Future Biomarkers in Alcoholic Hepatitis
    Stephanie M. Rutledge, Gene Young Im · 2021 · Clinics in Liver Disease
  2. Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis
    Hamish A. Innes, Alex J Walker, Jennifer Benselin, Jane I. Grove, Vincent Pedergnana, M. Azim Ansari, Shang‐Kuan Lin, John McLauchlan, Sharon J. Hutchinson, Eleanor J. Barnes et al. · 2022 · Clinical and Translational Gastroenterology
  3. Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis.
    Parita Patel, Steven L. Flamm · 2022 · PubMed Central
  4. Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis
    Hong Xia Fan, Zhenqiu Liu, Pengyan Zhang, Sheng Lan Wu, Xinyu Han, Yi‐Wen Huang, Yichen Zhu, Xingdong Chen, Tiejun Zhang · 2023 · Hepatology International
  5. Genomic approaches to explore susceptibility and pathogenesis of alcohol use disorder and alcohol-associated liver disease
    Trina M. Norden‐Krichmar, Daniel Miller Rotroff, Tae-Hwi Linus Schwantes-An, Ramon A. Bataller, David A Goldman, Laura E. Nagy, Suthat Liangpunsakul · 2023 · Hepatology
  6. Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease
    Marica Meroni, Miriam Longo, Paola Dongiovanni · 2020 · Exploration of Medicine
  7. Hepatocellular Carcinoma
    Rahmat Adetutu Adisa, Lateef Adegboyega Sulaimon · 2022 · IntechOpen eBooks
  8. Genetic polymorphisms associated with metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk susceptibility in the Chinese Han population
    Mingjia Dai, Yan Li, Jing Zhang, Yuhua Ruan, Ye Liu, Jungui Hao, Fang Ji, Xuebing Yan · 2025 · Human Genomics
  9. The versatile interplay between steatotic liver disease and liver cancer
    M. Rahbari, A. Gris-Oliver, P. Ramadori, David Aicher, D. Sia, Nisar Malek, R. Loomba, Ramón Bataller, J. Llovet, Mathias F. Heikenwälder · 2026 · Nature Reviews. Cancer
  10. Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD/MASH: Metabolic Mechanisms and Therapeutic Perspectives
    Jin Jin, C Chia-Kai Yang · 2026 · Metabolites
  11. HCC in MASLD and ALD: Biochemical Pathways, Epidemiology, Diagnosis, and Treatment
    Sheel A. Patel, Fares Kasem, Dylan T. Flaherty, Ashutosh J. Barve · 2025 · BioChem
  12. Genetic variation and elevated liver enzymes during childhood, adolescence and early adulthood
    Stefan Stender, George Davey Smith, Tom G. Richardson · 2023 · International Journal of Epidemiology
  13. Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases
    Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Milena Peruhova, Georgi Vasilev, Georgi Vasilev, Metodija Sekulovski, Snezhina Lazova, Milena Gulinac, L Tomov et al. · 2023 · Gastroenterology Insights
  14. The pharmacological management of alcohol-related cirrhosis: what’s new?
    Nipun Verma, Ashwin Pachat Vinod, Ashwani Kumar Singal · 2024 · Expert Opinion on Pharmacotherapy
  15. Diagnosis and Management of Early Stages of ALD
    Jordi Gratacós‐Ginès, Edilmar Alvarado‐Tápias, David Martí Aguado, Hugo López‐Pelayo, Ramon A. Bataller, Elisa Pose · 2025 · Seminars in Liver Disease
  16. Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation
    Ville Liukkonen, Maria Semenova, Kati Hyvärinen, Jouni Lauronen, Jukka Partanen, Johanna T. Arola, Arno J. Nordin, Martti A. Färkkilä, Fredrik O. Åberg · 2025 · Liver International
  17. Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis
    Hyun-seok Kim, Priya Bhatia Shetty, Spiridon Tsavachidis, Jing Dong, Christopher Ian Amos, Hashem B. El‐Serag, Aaron P. Thrift · 2022 · Clinical Gastroenterology and Hepatology
  18. Machine learning predicts liver cancer risk from routine clinical data: a large population-based multicentric study
    Jan Clusmann, Paul‐Henry Koop, David Y. Zhang, Felix van Haag, Omar S. M. El Nahhas, Tobias Seibel, Laura Žigutytė, Apichat Kaewdech, Julien Caldéraro, Frank Tacke et al. · 2024 · medRxiv
  19. Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes
    Qianchang Wang, Zhe Wang, Min Hu, Fangfeng Liu, Zhengjian Wang · 2025 · Frontiers in Medicine
  20. Advanced alcoholic liver disease driven by a proferroptotic diet
    Yonggang Liang, Yanchao Xu, Megan Virostek, Ann Johnson, Bret M. Evers, Yaqin Deng, Yawen Meng, Jeffrey G. McDonald, Philipp E. Scherer, Shaojie Cui et al. · 2025 · Journal of Lipid Research
  21. Clinical and molecular implications of antipsychotics in MASLD
    Celina Gonzalez-Peña, Misael Uribe, Norberto Carlos Chávez-Tapia · 2025 · Annals of Hepatology
  22. TM6SF2 in Hepatic Lipid Metabolism and Chronic Liver Disease
    Mustafa Al-Nakeb, Nils Haep · 2026 · Livers
  23. Monogenic and Polygenic Risk in Common Liver Diseases: Implications for Clinical Care
    Veeral H. Ajmera, Daniel Q. Huang, Vincent Lingzhi Chen, K. Rajender Reddy · 2026 · Gastroenterology
  24. Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study
    Julia Kozlitina, Naomi M Cohen, Drew Sturtevant, Jonathan C. Cohen, Cathi Murphey-Half, Jerome G. Saltarrelli, Peter Jindra, Medhat Z. Askar, Christine S. Hwang, Parsia A. Vagefi et al. · 2023 · EClinicalMedicine
  25. The Patatin-Like Phospholipase Domain–Containing 3 148M Variant Exacerbates Alcohol-Induced Liver Injury and Tumorigenesis in Mice
    Jung-Hyo Cho, Hyeong-Geug Kim, Menghao Huang, Shen Wang, Sheng Liu, Alex Z Lu, Kyle McCrocklin, Yang Zhang, Zhigang Fang, Juexin Wang et al. · 2025 · American Journal Of Pathology
  26. Sinnvolle genetische Untersuchungen in der Gastroenterologie
    Margarete Hohmann, Renate Schmelz, Jochen Hampe, Sebastian Zeißig · 2018 · DMW - Deutsche Medizinische Wochenschrift
  27. Hepatocellular Carcinoma: Aetiology and Mechanisms of Development. A Literature Review
    K. Menshikov, A. Sultanbaev, S. Musin, I. R. Rakhmatullina, I. A. Menshikova, R. R. Abdeev, N. Sultanbaeva, E. Popova, G. A. Serebrennikov · 2022 · Creative Surgery and Oncology
  28. Impact of alcohol consumption on metabolic dysfunction‐associated fatty liver disease development and remission: A longitudinal cohort study
    Masahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, Takanori Kashihara, Shota Fujmoto, Tomoyuki Kawaguchi, Reiko Yokoyama, Kaizo Kagemoto, Hironori Tanaka, Yoshifumi Kida et al. · 2024 · European Journal of Clinical Investigation
  29. The Causal Relationship between Inflammatory Cytokines and Liver Cirrhosis in European Descent: A Bidirectional Two-Sample Mendelian Randomization Study and the First Conclusions
    Shiya Shi, Yanjie Zhou, He Zhang, Yalan Zhu, Pengjun Jiang, Chengxia Xie, Tianyu Feng, Yuping Zeng, He He, Yao Luo et al. · 2024 · Biomedicines
  30. Khat chewing increases the risk for developing chronic liver disease: A hospital-based case-control study
    Stian Magnus Staurung Orlien, Irene Sandven, Nega Belay Berhe, Nejib Yusuf Ismael, Tekabe Abdosh Ahmed, Kathrine Stene‐Johansen, Svein Gunnar Gundersen, Marsha Yvonne Morgan, Asgeir Johannessen · 2018 · Journal of Hepatology
  31. The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study
    Goh Eun Chung, Eun‐Soon Shin, Min‐Sun Kwak, Jong In Yang, Jong-Eun Lee, Eun Kyung Choe, Jeong Yoon Yim · 2020 · BMC Gastroenterology
  32. Coexistent Alcohol-Related Liver Disease and Alcohol-Related Pancreatitis: Analysis of a Large Health Care System Cohort
    Gavin E. Arteel, Ajay Singhvi, Robert Feldman, Andrew D. Althouse, Ramon A. Bataller, Melissa I. Saul, Dhiraj Kumar Yadav · 2021 · Digestive Diseases and Sciences
  33. Molecular Alterations Caused by Alcohol Consumption in the UK Biobank: A Mendelian Randomisation Study
    Felix O’Farrell, Xiyun Jiang, Shahad Aljifri, Raha Pazoki · 2022 · Nutrients
  34. Etablierte Therapien und neue therapeutische Ansätze bei der alkoholischen Leberkrankung
    Helmut Seitz, Sebastian Mueller · 2016 · Zeitschrift für Gastroenterologie
  35. Suppressed Fat Mobilization Due to PNPLA3 rs738409 -Associated Liver Damage in Heavy Drinkers: The Liver Damage Feedback Hypothesis
    Vanessa Rausch, Sebastian Mueller · 2018 · Advances in experimental medicine and biology
  36. Genetic Variants of Alcohol Metabolizing Enzymes and Alcohol-Related Liver Cirrhosis Risk
    Pedro Ayuso, Elena García‐Martín, José Antonio Cornejo-García, José A. G. Agúndez, José M. Ladero · 2021 · Journal of Personalized Medicine
  37. Coexistent alcohol-related cirrhosis and chronic pancreatitis have a comparable phenotype to either disease alone: A comparative retrospective analysis
    Michael Lu, Yujie Sun, Robert Feldman, Melissa I. Saul, Andrew D. Althouse, Gavin E. Arteel, Dhiraj Kumar Yadav · 2023 · World Journal of Hepatology
  38. Predictive risk markers in alcoholism
    Onni J Niemelä · 2023 · Advances in clinical chemistry
  39. MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease
    Stefano Romeo · 2020 · Gastroenterology
  40. Conversational code-switching among Japanese-English bilinguals who have Japanese background
    Yoshiko Morishima · 1999 · Australasian Journal of Paramedicine
  41. The structure, catalytic mechanism, and inhibitor identification of phosphatidylinositol remodeling MBOAT7
    Kun Wang, Chia‐Wei Lee, Xuewu Sui, Siyoung Kim, Shuhui Wang, Aidan Higgs, Aaron Baublis, Gregory A. Voth, Maofu Liao, Tobias C. Walther et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Genes in Alcoholic Liver Disease: A Complex Interplay
    Saurabh Dawra, Manish Manrai · 2023 · Gene Expression
  43. Impact of genotyping (PTPN2, rs2542151) and (MBOAT7, rs641738) in prediction of fibrosis in Metabolic dysfunction- associated steatotic liver disease’ patients
    Shimaa Abdelsattar, Hiba Saeed A. Bagader Al-Amodi, Hala F. M. Kamel, Zeinab Abdel Aziz Kasemy, Ehab Darwish, Asmaa Mosbeh, Ayman Ahmed Sakr, Hanaa M. Elgazzar, Mervat M. Abdelkareem, Mai Abozeid et al. · 2025 · Frontiers in Endocrinology
  44. Effect of Hepatitis C Virus Genotype, Cirrhosis, and Viral Cure on Serum Phosphatidylinositol Species Profiles
    Kilian Weigand, Georg Peschel, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch, Martina Müller, Christa Buechler · 2025 · Biomedicines
  45. The Alpha‐1 Pi * MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD
    Lorenz Balcar, Georg Semmler, Bernhard Scheiner, Rafael Paternostro, Benedikt Simbrunner, Tina Jasmin Haunold, Mathias Jachs, Lukas Hartl, Benedikt Hofer, Nina Dominik et al. · 2026 · Alimentary Pharmacology & Therapeutics
  46. Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study
    Jan Clusmann, Paul‐Henry Koop, David Y. Zhang, Felix van Haag, Omar S. M. El Nahhas, Tobias Seibel, Laura Žigutytė, Apichat Kaewdech, Julien Caldéraro, Frank Tacke et al. · 2026 · Cancer Discovery
  47. Genetic risk of steatotic liver disease: Pathogenesis, prognosis, and implications for treatment
    Julia Kozlitina, Stefano Romeo, Helen H. Hobbs · 2026 · Hepatology
  48. Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making
    Mayada Metwally, Mohammed Eslam, Jacob George · 2017 · Current Hepatology Reports
  49. The Correlation between Single Nucleotide Polymorphism of MBOAT7 and PNPLA3 Genes to The Degree of Hepatic Fibrosis in HCV Patients: An Experience from Egypt
    Samar Samir Youssef, Eman Abbas, Yasser Aly, Sameh Mohamed Seif · 2020 · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research
  50. Clinically silent LINE 1 insertion in the PNPLA3 gene may impede genotyping of the p.I148M variant
    Martin Leníček, Vaclav Smid, Petr Pajer, Anna Nazarova, Karel Dvořák, Iva Subhanová, Radan Brůha, Libor Vı́tek · 2021 · Scientific Reports
  51. Molecular profiling in the management of hepatocellular carcinoma
    Nadine Soliman, Ashish Saharia, Maen Abdelrahim, Ashton Anthony Connor · 2023 · Current Opinion in Organ Transplantation
  52. Connection of cirrhosis in the outcome of alcoholic liver disease with the PNPLA3 gene polymorphism rs738409
    О. S. Pershenkova, Е. И. Михайлова · 2024 · Health and Ecology Issues
  53. Genetic Aspects of Non-alcoholic Fatty Liver Disease (NAFLD)
    Stefan Stender, Niels Grarup, Torben F. Hansen · 2018 · Springer eBooks
  54. Noncholesterol Sterols as Surrogate Markers in Patients with Severe Alcoholic Hepatitis
    Perttu Sahlman, Markku J. Nissinen, Piia P. Simonen, Martti A. Färkkilä · 2018 · Lipids
  55. Nicht alkoholische (NAFLE) und alkoholische Lebererkrankung (ALE)
    Helmut Karl Seitz, Sebastian Mueller · 2018 · CME
  56. Risk of chemotherapy-associated liver injury (CALI) in PNPLA3 p.148M allele carriers: Preliminary results of a transient elastography-based study
    Markus Casper, Simone Zimmermann, Susanne Nicole Weber, Anita Arslanow, Frank Lammert, Marcin Jan Krawczyk · 2019 · Digestive and Liver Disease
  57. PNPLA3 and TM6SF2, but Not MBOAT7, Are Associated with Steatosis and HBV Viral Persistence in Pakistani Population
    Ismail Jalil, Muhammad Arshad, Shahtaj Khan, Javid Iqbal Dasti · 2020 · Jundishapur Journal of Microbiology
  58. Enfermedad hepática inducida por alcohol
    Alexandre Figueroa Tubío, Juan Carlos Ruiz-Cobo, Luis Téllez Villajos, Rosa Martín‐Mateos · 2020 · Medicine - Programa de Formación Médica Continuada Acreditado
  59. NOTCH3 rs1043996 Polymorphism Is Associated with the Occurrence of Alcoholic Liver Cirrhosis Independently of PNPLA3 and TM6SF2 Polymorphisms
    Ana Bainrauch, Dino Šisl, Antonio Markotić, Ana Ostojić, Slavko Gašparov, Valerija Bralić Lang, Nataša Kovačić, Danka Grčević, Anna Mrzljak, Tomislav Kelava · 2021 · Journal of Clinical Medicine
  60. Molecular basis of liver disease
    Satdarshan P. Monga, Jaideep Behari · 2020 · Elsevier eBooks
  61. PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality
    Kalliopi Azariadis, Nikolaos Gatselis, Aggeliki Lyberopoulou, Pinelopi Arvaniti, Kalliopi Zachou, Stella Gabeta, George Ν. Dalekos · 2024 · Journal of Translational Autoimmunity
  62. Genetic Confounders of Liver Stiffness and Controlled Attenuation Parameter
    Vanessa Rausch, Johannes H. Mueller, Sebastian Mueller · 2020 · Springer eBooks
  63. Disorders of Intracellular Triglyceride and Phospholipid Metabolism
    Foudil Lamari, Francis Rossignol, Grant A. Mitchell · 2022 · Springer eBooks
  64. A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
    Asmaa Elsayed · 2020 · The Sydney eScholarship Repository (The University of Sydney)
  65. Membrane Bound O-Acyltransferase 7 (MBOAT7) Shapes Lysosomal Lipid Homeostasis and Function to Control Alcohol-Associated Liver Injury
    Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, Raghav Jain, Rakhee Banerjee, Anthony J. Horak, Megan R. McMullen, Emily Huang, Annette Bellar, Shuhui Wang Lorkowski et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Metabolic-associated fatty liver disease: epidemiology, natural history and diagnosis, current paradigm and definitions for MAFLD
    Angelo Armandi, Elisabetta Bugianesi · 2023 · Elsevier eBooks
  67. The Genetics of Alcohol-Related Liver Disease
    Hamish A. Innes, Felix Stickel · 2023 · Springer eBooks
  68. Interpreting elevated liver blood test results through a genetic lens: A genome‐wide association study
    Hamish A. Innes, Stephan Buch, Timothy James Kendall, Jonathan Andrew Fallowfield, Indra Neil Guha · 2024 · Liver International
  69. Alcohol-associated liver disease
    Ashwani Kumar Singal, Heer Mehta, Ana Paula Grotti Clemente, Juan Pablo Arab, Winston Dunn, Ramon A. Bataller · 2024 · Elsevier eBooks
  70. Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis
    Jun Wang, Dora Ding, Xiaorong Shao, Lily Ma, Jun Xu, Jason H. Melehani, Lisa B. Boyette, Timothy R. Watkins, Catherine Jia, Vladislav A. Malkov et al. · 2025 · Diabetes Obesity and Metabolism
  71. MetALD: new insights and unraveling therapeutic potential
    Yue Feng, PanShiLi Han, Tao Liu, Yanhang Gao · 2025 · Metabolism and Target Organ Damage
  72. Acute Alcoholic Hepatitis
    Stephanie M. Rutledge, Robert S. Brown · 2025 · Clinics in Liver Disease
  73. Loss of the E3 ubiquitin ligase MARCHF6 alters hepatic lipid metabolism and drives spontaneous hepatosteatosis
    Vinay Sachdev, Nienke M. van Loon, Jenina Kingma, Roelof Ottenhoff, Josephine M. E. Tan, Marlene van den Berg, Suzanne Duijst, Aldo Jongejan, Johannes H.M. Levels, Patrick C.N. Rensen et al. · 2026 · Molecular Metabolism
  74. Genetic and lifestyle determinants of lipid profiles in Japanese young adults: evidence from MBOAT7 rs641738
    Akira Kado, Yukiko Inoue, Takeya Tsutsumi, Mitsuhiro Fujishiro, Shintaro Yanagimoto · 2026 · Lipids in Health and Disease
  75. Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease
    Nicholas O. Davidson · 2026 · Circulation Research
  76. Meta‐Analysis: Redefining Liver Disease Risk in Heterozygous Alpha‐1 Antitrypsin Deficiency
    Adam M. Syanda, Dimitra Georgantaki, Riona Linn, Amara Agbai, Hassan Tahir, Manako Sakai, Richard J. Thompson, Mariam Molokhia, S. Tamir Rashid · 2026 · Alimentary Pharmacology & Therapeutics
  77. Genetik metabolischer und viraler Lebererkrankungen
    Toni Herta, Janett Fischer, Thomas Berg · 2017 · Die Gastroenterologie
  78. Overcoming Alcohol Addiction in Patients with Alcohol-Related Liver Disease
    Gene Young Im · 2019 · Current Hepatology Reports
  79. Molecular prognosis in liver cirrhosis
    Sai Krishna Athaluri Divakar, Yujin Hoshida · 2019 · Elsevier eBooks
  80. Molecular and Genetics-Based Diagnostics
    Frank Lammert · 2018 · Elsevier eBooks
  81. Impact of PNPLA3 (rs738409‐G) polymorphism on post‐transplant outcomes after liver transplantation for alcohol‐related liver disease
    Tae Woo Yoo, Kwang‐Woong Lee, Nam‐Joon Yi, Suk Kyun Hong, Jeong‐Moo Lee, Hyeyoung Kim, Jieun Lim, Sooin Seo, Kyung‐Suk Suh · 2020 · Clinical Transplantation
  82. Interferon lambda 4 genotype and pathway in alcoholic hepatitis
    Sidsel Hyldgaard Støy, Ewa Terczyńska‐Dyla, Sanne Skovgård Veidal, Kristoffer T. G. Rigbolt, Hendrik Vilstrup, Henning Grønbæk, Rune Hartmann, Thomas Damgaard Sandahl · 2021 · Scandinavian Journal of Gastroenterology
  83. Alcohol-related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study
    Gyöngyi Szabó, Patrick S. Kamath, Vijay H. Shah, Mark R. Thursz, Philippe Mathurin · 2018 · Hepatology
  84. Genome Editing and Fatty Liver
    Umar Hayat, Ali A. Siddiqui, Muhammad L. Farhan, Ahmed Haris, Nasir Hameed · 2022 · Advances in experimental medicine and biology
  85. MBOAT7 expression is associated with disease progression in COVID-19 patients
    Eman Radwan, Ahmed Abdelaziz, Manal Mandour, Abdel‐Raheim M. A. Meki, Maha M. Elkholy, Marwan N. Mohamed · 2024 · Molecular Biology Reports
  86. Racial Disparities of Alcohol-Associated Liver Disease and Its Complications in Hospitalized Patients With Alcohol Use Disorder
    Soo Young Hwang, Elina Stoffel, David Sooik Kim, Elizabeth C. Verna, Wei Zhang · 2024 · Gastro Hep Advances
  87. An Insight into the Genetic Predisposition of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Africa
    Yusuf Moolla, Veron Ramsuran · 2024 · Liver international communications.
  88. Latest Insights in Alcohol-Related Liver Disease and Alcoholic Hepatitis
    Vlad-Teodor Enciu, Priscila Mădălina Ologeanu, Alexandru Constantinescu, Carmen Georgeta Fierbinteanu-Braticevici · 2025 · Romanian Journal of Internal Medicine
  89. Parental liver disease mortality is associated with unfavorable outcomes in patients with alcohol-associated hepatitis
    Wanzhu Tu, Samer Gawrieh, Lauren Devore Nephew, Craig James McClain, Qing Tang, Srinivasan Dasarathy, Vatsalya Vatsalya, Douglas Alano Simonetto, Carla D. Kettler, Gyöngyi Szabó et al. · 2025 · Hepatology Communications
  90. Genetic drivers of liver cirrhosis: The role of SERPINA1 and PNPLA3 variants in disease onset and progression
    Mikolas Holinka, Soňa Fraňková, Světlana Adamcová Selčanová, Ľubomír Skladaný, Ondřej Fabián, Martin Květoň, Dušan Merta, Věra Adámková, Jaroslav Alois Hubacek, Veronika Pitova et al. · 2025 · PLoS ONE
  91. Genetisches Risiko bei metabolischer Fettlebererkrankung
    Roman Liebe, Verena Keitel · 2020 · Der Diabetologe
  92. Genetic predictors and pathophysiological features of non-alcoholic fat liver disease
    Olga Valentinovna Smirnova, Olga Leonidovna Moskalenko, Э. В. Каспаров, И. Э. Каспарова · 2021 · Meditsinskiy sovet = Medical Council
  93. Alcohol Induced Liver Disease
    Nora V. Bergasa · 2021 · Springer eBooks
  94. Schlanke Patienten
    Roman Liebe, Marcin Jan Krawczyk · 2022 · Springer eBooks
  95. New genetic insights into the development of alcohol-related cirrhosis
    Christine Weber · 2015 · Nature Reviews Gastroenterology & Hepatology
  96. Evidence for a role of genetics in alcoholic hepatitis: Data from the STOPAH randomized controlled trial
    Alexandre Louvet, Markus Peck‐Radosavljevic · 2017 · Journal of Hepatology
  97. Genomic studies in non-alcoholic fatty liver disease
    Yang‐Lin Liu · 2017
  98. Clinical Genomics of NAFLD
    Frank Lammert · 2020
  99. Hepatic Lipid Droplets in Liver Function and Disease
    Douglas G. Mashek, Wenqi Cui, Linshan Shang, Charles P. Najt · 2020
  100. Editorial: the polygenic risk of cirrhosis development
    Angelo Armandi, Jörn Markus Schattenberg · 2021 · Alimentary Pharmacology & Therapeutics